Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2005
06/30/2005CA2548249A1 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
06/30/2005CA2548216A1 Methods of administering water-soluble prodrugs of propofol for extended sedation
06/30/2005CA2548106A1 Therapeutic microparticles
06/30/2005CA2548105A1 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
06/30/2005CA2548100A1 Methods and compositions for treatment of interferon-resistant tumors
06/30/2005CA2548074A1 Injectable composition
06/30/2005CA2547329A1 A solid oral tooth whitening composition
06/30/2005CA2547195A1 Microemulsion preconcentrate comprising a renin inhibitor
06/30/2005CA2547060A1 Pharmaceutical preparation comprising an antibody against the egf receptor
06/30/2005CA2491338A1 A method for inhibiting the growth of gastrointestinal tract tumors
06/30/2005CA2491141A1 A new composition comprising cs
06/29/2005EP1547626A2 Carrier with solid fibrinogen and solid thrombin
06/29/2005EP1547619A2 Preparation of diagnostic agents
06/29/2005EP1547615A1 Remedy
06/29/2005EP1547607A1 Bacterial cell wall skeleton component preparation
06/29/2005EP1547604A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
06/29/2005EP1547601A1 Coating method
06/29/2005EP1547600A1 Female hormone-containing patch
06/29/2005EP1547599A1 Transparent eye drops containing latanoprost
06/29/2005EP1547595A1 Patch for transdermal administration
06/29/2005EP1547589A1 Pasting agent
06/29/2005EP1547588A1 Soft capsule preparation
06/29/2005EP1547587A1 Agent for reducing side effects of diclofenac
06/29/2005EP1547584A1 Particulate product comprising pantethine
06/29/2005EP1547583A2 Capsule comprising low-substituted cellulose ether
06/29/2005EP1547582A1 Method of producing lipid complexed camptothecin-carboxylate
06/29/2005EP1547581A1 Liposomal vaccine for the treatment of human hematological malignancies
06/29/2005EP1547580A1 Loading of a camptothecin drug into colloidal nanoparticles
06/29/2005EP1547579A1 Adhesive gel composition for iontophoresis preparation and process for producing the same
06/29/2005EP1547577A1 Antiaging composition
06/29/2005EP1547170A1 Method for manufacture of films containing insoluble solids embedded in cellulose-based films
06/29/2005EP1546232A2 New polymers and applications
06/29/2005EP1546173A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna
06/29/2005EP1546169A2 Triplex hairpin ribozyme
06/29/2005EP1545757A2 Perfluorocarbon emulsions with non-fluorinated surfactants
06/29/2005EP1545735A2 Method for incorporating cationic molecules into a substrate for increasing dispersibility of cationic molecules
06/29/2005EP1545661A2 Method and device for painless injection of medication
06/29/2005EP1545656A1 An infusion pump system, an infusion pump unit and an infusion pump
06/29/2005EP1545634A2 Method of preparing dry powder inhalation compositions
06/29/2005EP1545622A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof
06/29/2005EP1545620A1 Pharmaceutical compositions comprising cyclosporin for oral administration
06/29/2005EP1545619A2 Solution for ungual application
06/29/2005EP1545593A1 Nucleic acid coated particles
06/29/2005EP1545563A1 Composition and method for use in intestinal cleansing procedures
06/29/2005EP1545550A2 Isosorbide mononitrate compositions and methods of their use
06/29/2005EP1545548A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
06/29/2005EP1545547A1 17&bgr;-ESTRADIOL/LEVONORGESTREL TRANSDERM PATCH FOR HORMONE REPLACEMENT THERAPY
06/29/2005EP1545516A2 Topical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
06/29/2005EP1545503A2 Pharmaceuticals formulations and methods for modified release of statin drugs
06/29/2005EP1545500A1 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof
06/29/2005EP1545499A1 Composition for solubilization of paclitaxel and preparation method thereof
06/29/2005EP1545495A1 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
06/29/2005EP1545488A1 Choline ascorbate formulations
06/29/2005EP1545486A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
06/29/2005EP1545480A1 Breath freshening and oral cleansing product using citral
06/29/2005EP1545477A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
06/29/2005EP1545476A1 Chronotherapeutic diltiazem formulations and the administration thereof
06/29/2005EP1545475A1 Enteric composition for the manufacture of soft capsule wall
06/29/2005EP1545474A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
06/29/2005EP1545473A2 Modified release, multiple unit drug delivery systems
06/29/2005EP1545472A1 Modified release dosage forms with two cores and an opening
06/29/2005EP1545471A1 Storage stable tablets of fosinopril sodium
06/29/2005EP1545470A2 Anti-microbial compositions and methods of using same
06/29/2005EP1545469A1 Method to improve pharmaceutical tablets having a matrix of cellulose ether
06/29/2005EP1545468A2 Sustained-release opioid formulations and methods of use
06/29/2005EP1545467A1 Solid pharmaceutical formulations comprising telmisartan
06/29/2005EP1545466A1 Inorganic shaped bodies and methods for their production and use
06/29/2005EP1545465A1 Delayed release anti-viral product, use and formulation thereof
06/29/2005EP1545464A2 Method and compositions for preparing and delivering rumen protected lipids, other nutrients and medicaments
06/29/2005EP1545463A1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
06/29/2005EP1545462A2 Dendrimers as molecular translocators
06/29/2005EP1545461A2 Combined immediate release and extended release analgesic composition
06/29/2005EP1545459A2 Platinum aggregates and process for producing the same
06/29/2005EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
06/29/2005EP1545457A2 Cell transport compositions and uses thereof
06/29/2005EP1545455A1 Controlled delivery system for bioactive substances
06/29/2005EP1545454A1 Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
06/29/2005EP1545453A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
06/29/2005EP1545452A1 Modified release dosage forms
06/29/2005EP1545448A2 Breath freshening and oral cleansing product using geraniol
06/29/2005EP1545447A2 Breath freshening and oral cleansing product using salicylaldehyde
06/29/2005EP1545429A2 Methods and compositions for treatment of dermal conditions
06/29/2005EP1545412A1 Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
06/29/2005EP1545233A1 Chewing gum containing calcium salt
06/29/2005EP1545231A1 Sweet containing calcium
06/29/2005EP1545211A1 Nodulisporic acid derivative spot-on formulations for combating parasites
06/29/2005EP1545208A2 Methods of using beta glucan as a radioprotective agent
06/29/2005EP1443948B1 Process for the preparation of anthocyanin-containing products
06/29/2005EP1421093B1 Crystaline clindamycin free base
06/29/2005EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent
06/29/2005EP1379161A4 Skin patch including a temperature sensor
06/29/2005EP1339408B1 Liquid drug formulations having improved oral tolerability
06/29/2005EP1276505A4 Mixtures of triblock polyesterpolyethylene glycol copolymers
06/29/2005EP1239873B1 Use of fibrinolytic metalloproteinases for the therapeutic treatment of a blood clot
06/29/2005EP1225951B1 A dual adhesive transdermal drug delivery system
06/29/2005EP1165077B1 Viral treatment
06/29/2005EP1152762B8 Use of desoxypeganine in the treatment of alzheimer's dementia
06/29/2005EP1146861B1 Hydrogel particle formulations
06/29/2005EP1140114B1 Pharmaceutical formulations
06/29/2005EP0977614B1 Device for treating malignant, tumorous areas of tissue
1 ... 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 ... 2991